Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Net Margin (2022 - 2025)

Historic Net Margin for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 126560.0%.

  • PAVmed's Net Margin changed N/A to 126560.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 12206.9%, marking a year-over-year change of. This contributed to the annual value of 1081.6% for FY2024, which is 37842900.0% up from last year.
  • Per PAVmed's latest filing, its Net Margin stood at 126560.0% for Q3 2025.
  • In the past 5 years, PAVmed's Net Margin registered a high of 221250.0% during Q1 2025, and its lowest value of 221800.0% during Q2 2025.
  • Its 4-year average for Net Margin is 17298.82%, with a median of 8802.41% in 2023.
  • The largest annual percentage gain for PAVmed's Net Margin in the last 5 years was 2000000000bps (2025), contrasted with its biggest fall of 2000000000bps (2025).
  • Quarter analysis of 4 years shows PAVmed's Net Margin stood at 18332.14% in 2022, then surged by 92bps to 1516.21% in 2023, then plummeted by -958bps to 16040.0% in 2024, then tumbled by -689bps to 126560.0% in 2025.
  • Its Net Margin was 126560.0% in Q3 2025, compared to 221800.0% in Q2 2025 and 221250.0% in Q1 2025.